Home » Regions » Asia » WuXi PharmaTech wins Asian CRO award

WuXi PharmaTech wins Asian CRO award

Monday, October 19, 2015

WuXi PharmaTech, a Shanghai-based open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries, has received the 2015 Asian CRO Company of the Year award from Frost & Sullivan, a business research and consulting firm.

The award is part of the Frost & Sullivan Asia Pacific Best Practices Awards series, recognizing companies in Asia Pacific that demonstrate outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development.

WuXi is being recognized for its strong performance and continued investments in the Asia Pacific region. Frost & Sullivan cited WuXi’s local market knowledge, facilities, reputation for high-quality, rapid turnaround times, comprehensive customer support and strong commitment to the highest global regulatory standards.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!